SCHEMBL2813063

SCHEMBL2813063

COc1ccc(O/C=C(\C)C(=O)Nc2ccccc2)c(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.48
ALDH1A1 P00352 5/20 0.48
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
MAPT P10636 4/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 8/20 0.46
MEN1 O00255 7/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
STAT1 P42224 1/20 0.46
GAA P10253 2/20 0.46
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
HSD17B10 Q99714 1/20 0.45
RCE1 Q9Y256 1/20 0.45
HTT P42858 1/20 0.45
PKM P14618 2/20 0.44
KLF5 Q13887 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2813069 1.00 HIF1A (0.48) HIF1AALDH1A1NPC1RAB9AMAPT
SCHEMBL2809079 0.87 NPSR1 (0.48) HIF1AALDH1A1NPC1RAB9AMAPT
SCHEMBL2809083 0.87 NPSR1 (0.48) HIF1AALDH1A1NPC1RAB9AMAPT
SCHEMBL2808806 0.86 RAB9A (0.53) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL2808802 0.86 RAB9A (0.53) ALDH1A1NPC1RAB9AMAPTKMT2A
SCHEMBL2810917 0.84 SMN1; SMN2 (0.55) HIF1AALDH1A1NPC1RAB9AMAPT
SCHEMBL2810919 0.84 SMN1; SMN2 (0.55) HIF1AALDH1A1NPC1RAB9AMAPT
SCHEMBL2811950 0.83 NPC1 (0.55) HIF1ANPC1RAB9AKMT2AMEN1
SCHEMBL2811952 0.83 NPC1 (0.55) HIF1ANPC1RAB9AKMT2AMEN1
SCHEMBL2811515 0.81 CA12 (0.52) ALDH1A1NPC1RAB9AMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-8278473-B2 Alpha, beta-unsaturated imidate compound and pesticidal composition containing the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-10-02 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-23 US disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed
WO-2009064031-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240729-A1 ALPHA, BETA-UNSATURATED IMIDATE COMPOUND AND PESTICIDAL COMPOSITION CONTAINING THE SAME OXER1, CBR1, DEGS1 HIF1A 2986/4885ALDH1A1 405/4885NPC1 3668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.